Buscar
Mostrando ítems 31-40 de 269
Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison
(Public Library of Science, 2018)
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
(Nature Medicine, 2021)
Balance between retroviral latency and transcription : based on HIV model
(MDPI, 2021-01)
The representative of the Lentivirus genus is the human immunodeficiency virus type 1 (HIV-1), the causative agent of acquired immunodeficiency syndrome (AIDS). To date, there is no cure for AIDS because of the existence ...
Pre-cART immune parameters in people living with HIV might help predict CD8+ T-cell characteristics, inflammation levels, and reservoir composition after effective cART
(Case Western Reserve University, 2021-08)
Background: Combined antiretroviral treatment (cART) for HIV infection is highly effective in controlling viral replication. However, it cannot achieve a sterilizing cure. Several strategies have been proposed to achieve ...
Novas abordagens terapêuticas com células-tronco na cura do HIV - revisão de literatura
(Faculdade de Medicina da BahiaUFBABrasil, 2015-05-06)
NOVAS ABORDAGENS TERAPÊUTICAS COM CÉLULAS-TRONCO NA
CURA DO HIV – REVISÃO DE LITERATURA. Objetivo: Pesquisar na
literatura especializada as formas de terapia com células-tronco que se
aplicam à cura e tratamento do ...
Linfoma de Burkitt en pacientes HIV positivo tratados con quimioterapia intensiva en el Hospital del Salvador entre 2011 y 2014. Protocolo Nacional de Cáncer del Adulto, Chile
(Sociedad Médica de Santiago, 2015)
Background: Burkitt lymphoma has a low incidence, is highly aggressive, may be endemic, sporadic or associated with immunodeficiency and it has a high frequency of extranodal involvement. Overall and relapse free survival ...